miR-224 is Critical for Celastrol-Induced Inhibition of Migration and Invasion of Hepatocellular Carcinoma Cells, Cellular Physiology and Biochemistry, vol.32, issue.2, pp.448-458 ,
DOI : 10.1159/000354450
Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis, Biology of the Cell, vol.297, issue.9, pp.414-429, 2013. ,
DOI : 10.1111/boc.201300021
Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Metdeficient hepatocellular carcinoma in vivo, MolBiolRep2013, issue.7, pp.404203-4209 ,
Celastrol causes apoptosis and cell cycle arrest in rat glioma cells, Neurological Research, vol.33, issue.1, pp.94-100, 2010. ,
DOI : 10.1158/0008-5472.CAN-05-2321
Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signalingcascadeinvitroandinvivo, Cancer Prev Res (Phila), vol.2012, issue.54, pp.631-643 ,
Celastrols as Inducers of the Heat Shock Response and Cytoprotection, Journal of Biological Chemistry, vol.279, issue.53, pp.27956053-56060 ,
DOI : 10.1074/jbc.M409267200
Celastrol Blocks Neuronal Cell Death and Extends Life in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases, vol.2, issue.5, pp.246-254, 2005. ,
DOI : 10.1159/000090364
Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease, BMC Neuroscience, vol.10, issue.1, p.109, 2009. ,
DOI : 10.1186/1471-2202-10-109
The Extent of Neurodegeneration and Neuroprotection in Two Chemical In Vitro Models Related to Parkinson???s Disease is Critically Dependent on Cell Culture Conditions, Neurotoxicity Research, vol.22, issue.Suppl 17, pp.41-54, 2013. ,
DOI : 10.1007/s12640-012-9374-z
Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90, European Journal of Pharmaceutical Sciences, vol.50, issue.1, pp.149-158 ,
DOI : 10.1016/j.ejps.2013.04.001
A systematic protocol for the characterization of Hsp90 modulators, Bioorganic & Medicinal Chemistry, vol.19, issue.1, pp.684-692, 2011. ,
DOI : 10.1016/j.bmc.2010.10.029
Tripterine inhibits the expression of adhesion molecules in activated endothelial cells, Journal of Leukocyte Biology, vol.80, issue.2, pp.309-319, 2006. ,
DOI : 10.1189/jlb.1005611
URL : https://hal.archives-ouvertes.fr/inserm-00180304
Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets, ACS Chem Biol, vol.2012, issue.75, pp.928-937 ,
Use of formalinfixed , propidium iodide-stained human leukocytes as a standard for enumerating CD4+ T lymphocytes in a single-platform assay, Clin Diagn Lab Immunol, vol.8, issue.2, pp.397-401, 2001. ,
A routinely applicable way for using FCM in cell enumeration with CFSE-labeled Cell Beads as internal standard, Cytometry A, issue.12, pp.75975-978, 2009. ,
Monitoring the induction of heat shock factor 1/heat shock protein 70 expression following 17-allylamino- demethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging, Mol Imaging, vol.2012, issue.111, pp.67-76 ,
Modulation of Hsf1 activity by novobiocin and geldanamycin, Biochemistry and Cell Biology, vol.87, issue.6, pp.845-851, 2009. ,
DOI : 10.1139/O09-049
Induction of heat shock proteins in cerebral cortical cultures by celastrol, Cell Stress and Chaperones, vol.86, issue.Suppl 2, pp.155-160 ,
DOI : 10.1007/s12192-012-0364-0
Celastrol can inhibit proteasome activity and upregulate the expression of heat shock protein genes, hsp30 and hsp70, in Xenopus laevis A6 cells, Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, vol.156, issue.2, pp.285-293, 2010. ,
DOI : 10.1016/j.cbpa.2010.02.015
Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response, Journal of Molecular Medicine, vol.72, issue.12, pp.1421-1428, 2007. ,
DOI : 10.1007/s00109-007-0251-9
HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way, Molecular Cancer, vol.9, issue.1, p.79, 2010. ,
DOI : 10.1186/1476-4598-9-79
URL : https://hal.archives-ouvertes.fr/inserm-00668221
Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network, Journal of Neurochemistry, vol.334, issue.2, pp.256-266 ,
DOI : 10.1111/jnc.12474
Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling, Apoptosis, vol.557, issue.12, pp.171275-1286 ,
DOI : 10.1007/s10495-012-0767-5
Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway, Cancer Research, vol.70, issue.5, pp.1951-1959, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-3201
Protective effect of celastrol in rat cerebral ischemia model: Down-regulating p-JNK, p-c-Jun and NF-??B, Brain Research, vol.1464, pp.8-13, 2012. ,
DOI : 10.1016/j.brainres.2012.04.054
Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid, Biochem Pharmacol, issue.10, pp.721311-1321, 2006. ,
Celastrol Acts as a Potent Antimetastatic Agent Targeting ??1 Integrin and Inhibiting Cell-Extracellular Matrix Adhesion, in Part via the p38 Mitogen-Activated Protein Kinase Pathway, Journal of Pharmacology and Experimental Therapeutics, vol.334, issue.2, pp.489-499, 2010. ,
DOI : 10.1124/jpet.110.165654
Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMP-mediated proMMP-2 activation, Cancer Letters, vol.279, issue.2, pp.171-176, 2009. ,
DOI : 10.1016/j.canlet.2009.01.032
Actinonin, a Meprin a Inhibitor, Protects the Renal Microcirculation During Sepsis, Shock, vol.35, issue.2, pp.141-147, 2011. ,
DOI : 10.1097/SHK.0b013e3181ec39cc
Overexpression of peptide deformylase in breast, colon, and lung cancers, BMC Cancer, vol.387, issue.5, p.321, 2013. ,
DOI : 10.1016/j.jmb.2009.02.032